; (2) $782,193,000 is for Research, Development, Test, and Evaluation; and (3) $616,000 is for Procurement. (b) Use Amounts authorized to be appropriated under subsection (a) are authorized for— (1) the destruction of lethal chemical agents and munitions in accordance with section 1412 of the Department of Defense Authorization Act, 1986 ( 50 U.S.C. 1521 ); and (2) the destruction of chemical warfare materiel of the United States that is not covered by section 1412 of such Act. 1403. Drug interdiction and counter-drug activities, defense Funds are hereby authorized to be appropriated for the Department of Defense for fiscal year 2021 for expenses, not otherwise provided for, for Drug Interdiction and Counter-Drug Activities, Defense, in the amount of $769,629,000. 1404. Defense Inspector General Funds are hereby authorized to be appropriated for the Department of Defense for fiscal year 2021 for expenses, not otherwise provided for, for the Office of the Inspector General of the Department of Defense, in the amount of $371,439,000 of which— (1) $369,483,000 is for Operation and Maintenance; (2) $1,098,000 is for Research, Development, Test and Evaluation; and (3) $858,000 is for Procurement. 1405. Defense Health Program Funds are hereby authorized to be appropriated for the Department of Defense for fiscal year 2021 for expenses, not otherwise provided for, for the Defense Health Program, in the amount of $32,690,372,000 of which— (1) $31,349,553,000 is for Operation and Maintenance; (2) $562,465,000 is for Research, Development, Test, and Evaluation; (3) $617,926,000 is for Procurement